Asthma is one of the major noncommunicable diseases, and is an important cause of chronic suffering, disability and preventable deaths in the world. Everyday activities become a huge challenge for the world’s of asthma sufferers, says the Chair of the Global Asthma Network Professor Innes Asher from The University of Auckland.
“Asthma causes disabling symptoms in millions of people who struggle to breathe, making ordinary activities extraordinarily difficult – things like going to school, working at a job, looking after children or ageing parents, running or even walking”, explains Professor Asher. “We know that about 1000 people die from asthma each day – far more than most people realise. The tragedy is that most of these deaths are actually preventable”.
On Sunday 26 March 2017 investigators from all 9 of the Indian GAN centres met at Asthma Bhawan, Jaipur.
We are delighted to announce that Prof Innes Asher has been appointed to the WHO Expert Panel on NCDs, as an expert in chronic respiratory diseases. Prof Asher, who was recently interviewed for World TV (7:48-10:33) said, "I feel very honoured by this appointment, which is a great accolade for the Global Asthma Network".
Global Asthma Network survey suggests more national asthma strategies could reduce burden of asthma
Asher I, et al. Global Asthma Network survey suggests more national asthma strategies could reduce burden of asthma. Allergol Immunopathol (Madr). 2017. http://dx.doi.org/10.1016/j.aller.2016.10.013.
The Global Asthma Network Rationale and Methods for Phase I Global Surveillance: Prevalence, Severity, Management and Risk Factors
Ellwood P, Asher MI, Billo NE, et al. The Global Asthma Network rationale and methods for Phase I global surveillance: prevalence, severity, management and risk factors. Eur Respir J, 2017; 49: 1601605. http://dx.doi.org/10.1016/j.aller.2016.10.013.
Two posters relating to GAN research were presented at the 26th European Respiratory Society International Congress, held 3-7 September 2016 in London:
PA4186: Global Asthma Network identifies gaps in essential asthma medicines
PA4187: Global Asthma Network survey of national asthma strategies Where are the gaps?
Professor Luis Garcia-Marcos is currently at the American Thoracic Society (ATS) meeting in San Francisco, California. He is manning a GAN booth in the Global Community section of the Exhibitor Hall (Booth GC7). The ATS runs from May 13 to 18th.
Almost 1000 people die from asthma each day – far more than most people realise. The tragedy is that most of these deaths are potentially preventable.
Deaths from asthma are the tip of the iceberg of poor asthma control – asthma is a serious chronic disease, causing widespread disability and suffering at all ages. The effects on people with asthma and their families are bad enough, and the resultant loss of productivity results in huge costs to society; US$56 billion/year in the US alone. Bringing asthma symptoms under control requires solutions at global, national, local, community, family and individual levels.
Following the success of the GAN booth at the American Thoracic Society (ATS) in San Diego last year, we are again this year having a GAN booth in the exhibitor’s hall at the ATS 2016 International Conference scheduled for 13-18 May 2016 at the Moscone Center, San Francisco, USA.
Professor Luis García-Marcos, GAN Steering Group member from Murcia, Spain, has kindly offered to be present at the booth to meet any one that is going to the ATS this year and who would like to discuss any GAN related matters. The booth number is GC 7 and located in the Exhibitor Hall in the section named Global Community.
Please note: There will not be anyone at the stand on Sunday 15 May as Professor García-Marcos has to be at his poster presentations on that day.